BiomX
Phage therapy
Ness Ziona, Israel · Founded 2015 · $56.0M raised
- Headquarters
- Ness Ziona, Maryland
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- biomx.com
- Total Funding
- $56.0M
- Last Round
- $32.0M Series BFeb 2019
- Rounds
- 2
About
Clinical‑stage company developing natural and engineered bacteriophage cocktails and personalized phage therapies to target harmful bacteria in chronic diseases.
Summary
BiomX is a Biotech company based in Ness Ziona, Israel, founded in 2015. It has raised $56.0M in total across 2 rounds, most recently a $32.0M Series B round in Feb 2019. Investors include Deerfield Management, OrbiMed and Johnson & Johnson Innovation.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...